Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

James W. Murrough, Andrew M. Perez, Sarah Pillemer, Jessica Stern, Michael K. Parides, Marije Aan Het Rot, Katherine A. Collins, Sanjay J. Mathew, Dennis S. Charney, Dan V. Iosifescu

Research output: Contribution to journalArticle

305 Citations (Scopus)

Abstract

Background: Ketamine is reported to have rapid antidepressant effects; however, there is limited understanding of the time-course of ketamine effects beyond a single infusion. A previous report including 10 participants with treatment-resistant major depression (TRD) found that six ketamine infusions resulted in a sustained antidepressant effect. In the current report, we examined the pattern and durability of antidepressant effects of repeated ketamine infusions in a larger sample, inclusive of the original. Methods: Participants with TRD (n = 24) underwent a washout of antidepressant medication followed by a series of up to six IV infusions of ketamine (.5 mg/kg) administered open-label three times weekly over a 12-day period. Participants meeting response criteria were monitored for relapse for up to 83 days from the last infusion. Results: The overall response rate at study end was 70.8%. There was a large mean decrease in Montgomery-Åsberg Depression Rating Scale score at 2 hours after the first ketamine infusion (18.9 ± 6.6, p <.001), and this decrease was largely sustained for the duration of the infusion period. Response at study end was strongly predicted by response at 4 hours (94% sensitive, 71% specific). Among responders, median time to relapse after the last ketamine infusion was 18 days. Conclusions: Ketamine was associated with a rapid antidepressant effect in TRD that was predictive of a sustained effect. Future controlled studies will be required to identify strategies to maintain an antidepressant response among patients who benefit from a course of ketamine.

Original languageEnglish (US)
Pages (from-to)250-256
Number of pages7
JournalBiological Psychiatry
Volume74
Issue number4
DOIs
StatePublished - Aug 15 2013
Externally publishedYes

Fingerprint

Treatment-Resistant Depressive Disorder
Ketamine
Antidepressive Agents
Recurrence
Depression

Keywords

  • Antidepressant
  • experimental therapeutics
  • glutamate
  • ketamine
  • major depressive disorder
  • treatment-resistant depression

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. / Murrough, James W.; Perez, Andrew M.; Pillemer, Sarah; Stern, Jessica; Parides, Michael K.; Aan Het Rot, Marije; Collins, Katherine A.; Mathew, Sanjay J.; Charney, Dennis S.; Iosifescu, Dan V.

In: Biological Psychiatry, Vol. 74, No. 4, 15.08.2013, p. 250-256.

Research output: Contribution to journalArticle

Murrough, JW, Perez, AM, Pillemer, S, Stern, J, Parides, MK, Aan Het Rot, M, Collins, KA, Mathew, SJ, Charney, DS & Iosifescu, DV 2013, 'Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression', Biological Psychiatry, vol. 74, no. 4, pp. 250-256. https://doi.org/10.1016/j.biopsych.2012.06.022
Murrough, James W. ; Perez, Andrew M. ; Pillemer, Sarah ; Stern, Jessica ; Parides, Michael K. ; Aan Het Rot, Marije ; Collins, Katherine A. ; Mathew, Sanjay J. ; Charney, Dennis S. ; Iosifescu, Dan V. / Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. In: Biological Psychiatry. 2013 ; Vol. 74, No. 4. pp. 250-256.
@article{534d658db449406eb9b9b40b1ee28af8,
title = "Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression",
abstract = "Background: Ketamine is reported to have rapid antidepressant effects; however, there is limited understanding of the time-course of ketamine effects beyond a single infusion. A previous report including 10 participants with treatment-resistant major depression (TRD) found that six ketamine infusions resulted in a sustained antidepressant effect. In the current report, we examined the pattern and durability of antidepressant effects of repeated ketamine infusions in a larger sample, inclusive of the original. Methods: Participants with TRD (n = 24) underwent a washout of antidepressant medication followed by a series of up to six IV infusions of ketamine (.5 mg/kg) administered open-label three times weekly over a 12-day period. Participants meeting response criteria were monitored for relapse for up to 83 days from the last infusion. Results: The overall response rate at study end was 70.8{\%}. There was a large mean decrease in Montgomery-{\AA}sberg Depression Rating Scale score at 2 hours after the first ketamine infusion (18.9 ± 6.6, p <.001), and this decrease was largely sustained for the duration of the infusion period. Response at study end was strongly predicted by response at 4 hours (94{\%} sensitive, 71{\%} specific). Among responders, median time to relapse after the last ketamine infusion was 18 days. Conclusions: Ketamine was associated with a rapid antidepressant effect in TRD that was predictive of a sustained effect. Future controlled studies will be required to identify strategies to maintain an antidepressant response among patients who benefit from a course of ketamine.",
keywords = "Antidepressant, experimental therapeutics, glutamate, ketamine, major depressive disorder, treatment-resistant depression",
author = "Murrough, {James W.} and Perez, {Andrew M.} and Sarah Pillemer and Jessica Stern and Parides, {Michael K.} and {Aan Het Rot}, Marije and Collins, {Katherine A.} and Mathew, {Sanjay J.} and Charney, {Dennis S.} and Iosifescu, {Dan V.}",
year = "2013",
month = "8",
day = "15",
doi = "10.1016/j.biopsych.2012.06.022",
language = "English (US)",
volume = "74",
pages = "250--256",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression

AU - Murrough, James W.

AU - Perez, Andrew M.

AU - Pillemer, Sarah

AU - Stern, Jessica

AU - Parides, Michael K.

AU - Aan Het Rot, Marije

AU - Collins, Katherine A.

AU - Mathew, Sanjay J.

AU - Charney, Dennis S.

AU - Iosifescu, Dan V.

PY - 2013/8/15

Y1 - 2013/8/15

N2 - Background: Ketamine is reported to have rapid antidepressant effects; however, there is limited understanding of the time-course of ketamine effects beyond a single infusion. A previous report including 10 participants with treatment-resistant major depression (TRD) found that six ketamine infusions resulted in a sustained antidepressant effect. In the current report, we examined the pattern and durability of antidepressant effects of repeated ketamine infusions in a larger sample, inclusive of the original. Methods: Participants with TRD (n = 24) underwent a washout of antidepressant medication followed by a series of up to six IV infusions of ketamine (.5 mg/kg) administered open-label three times weekly over a 12-day period. Participants meeting response criteria were monitored for relapse for up to 83 days from the last infusion. Results: The overall response rate at study end was 70.8%. There was a large mean decrease in Montgomery-Åsberg Depression Rating Scale score at 2 hours after the first ketamine infusion (18.9 ± 6.6, p <.001), and this decrease was largely sustained for the duration of the infusion period. Response at study end was strongly predicted by response at 4 hours (94% sensitive, 71% specific). Among responders, median time to relapse after the last ketamine infusion was 18 days. Conclusions: Ketamine was associated with a rapid antidepressant effect in TRD that was predictive of a sustained effect. Future controlled studies will be required to identify strategies to maintain an antidepressant response among patients who benefit from a course of ketamine.

AB - Background: Ketamine is reported to have rapid antidepressant effects; however, there is limited understanding of the time-course of ketamine effects beyond a single infusion. A previous report including 10 participants with treatment-resistant major depression (TRD) found that six ketamine infusions resulted in a sustained antidepressant effect. In the current report, we examined the pattern and durability of antidepressant effects of repeated ketamine infusions in a larger sample, inclusive of the original. Methods: Participants with TRD (n = 24) underwent a washout of antidepressant medication followed by a series of up to six IV infusions of ketamine (.5 mg/kg) administered open-label three times weekly over a 12-day period. Participants meeting response criteria were monitored for relapse for up to 83 days from the last infusion. Results: The overall response rate at study end was 70.8%. There was a large mean decrease in Montgomery-Åsberg Depression Rating Scale score at 2 hours after the first ketamine infusion (18.9 ± 6.6, p <.001), and this decrease was largely sustained for the duration of the infusion period. Response at study end was strongly predicted by response at 4 hours (94% sensitive, 71% specific). Among responders, median time to relapse after the last ketamine infusion was 18 days. Conclusions: Ketamine was associated with a rapid antidepressant effect in TRD that was predictive of a sustained effect. Future controlled studies will be required to identify strategies to maintain an antidepressant response among patients who benefit from a course of ketamine.

KW - Antidepressant

KW - experimental therapeutics

KW - glutamate

KW - ketamine

KW - major depressive disorder

KW - treatment-resistant depression

UR - http://www.scopus.com/inward/record.url?scp=84880767967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880767967&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2012.06.022

DO - 10.1016/j.biopsych.2012.06.022

M3 - Article

VL - 74

SP - 250

EP - 256

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 4

ER -